NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/15/2023
Back to search
Official data from USPTO
ORABODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
11/18/2023
Trademark type
Word
Nice classes
5
Filing date
08/24/2016
Registration date
11/14/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2023
Last transaction
11/18/2023
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/28/2015
First use in commerce
08/01/2016
Drawing code
4
Owner type
03
Owner location
Vacaville, CA, US
Examiner
CHARLON, BARNEY
Law office
L40
Current location
TMEG LAW OFFICE 104
Holders and representatives
Holders
Landing Biotech, Inc.
Landing Biotech, Inc.
Representatives
Landing Biotech, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the prevention and treatment of cancer
Publications
History of USPTO decisions and trademark events.
22 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
11/15/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11/09/2023
PUM1
OFFICE ACTION ISSUED POU1
11/21/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/20/2022
ES8R
TEAS SECTION 8 RECEIVED
11/15/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/14/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/14/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/12/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/11/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/18/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/18/2017
IUAF
USE AMENDMENT FILED
09/01/2017
EISU
TEAS STATEMENT OF USE RECEIVED
09/01/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/08/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2017
PUBO
PUBLISHED FOR OPPOSITION
01/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/21/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/04/2016
DOCK
ASSIGNED TO EXAMINER
12/04/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/30/2016
NWAP
NEW APPLICATION ENTERED
08/27/2016
Continuous trademark protection
Get notified about every new filing that threatens ORABODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.